Followers | 240 |
Posts | 12051 |
Boards Moderated | 0 |
Alias Born | 04/05/2009 |
Sunday, January 23, 2022 2:35:41 PM
Announces Formation of Special Committee
Dallas, TX, November 24, 2021 – SWK Holdings Corporation (Nasdaq: SWKH) (the “Company” or “SWK”) confirmed that on November 23, 2021, it received a non-binding proposal from funds managed by Carlson Capital, L.P. (“Carlson”) to acquire all shares of SWK not already owned by Carlson for a price of $19.00 per share, payable in cash. (the “Proposed Acquisition”). This proposal is not related to the prior proposal submitted by Carlson to the Company in April 2021.
The Company’s Board of Directors (the “Board”) has formed a special committee of non-executive, independent directors (the “Special Committee”). The Special Committee, in consultation with its advisors, will carefully review and consider Carlson’s proposal and pursue the course of action that it believes is in the best interests of the Company’s stockholders. The Company’s stockholders do not need to take any action at this time.
JMP Securities LLC is serving as financial advisor to the Special Committee and Shearman & Sterling LLP is acting as legal counsel.
There can be no assurance that a definitive proposal relating to the Proposed Acquisition will be made, that any such proposal will be recommended or accepted by the Special Committee, that a definitive agreement relating to the Proposed Acquisition or any other transaction will be entered into by the Company or that any transaction will be consummated. The Company does not undertake any obligation to provide any updates with respect to this or any other transaction, except as required under applicable law.
About SWK Holdings:
SWK is a specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK’s business partners and its investors. SWK believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. SWK also owns Enteris Biopharma (“Enteris”), whose core Peptelligence™ drug delivery technology creates oral formulations of peptide-based and BCS class II, III, and IV small molecules. With Enteris, SWK has the opportunity to grow its specialty finance business by actively building a wholly-owned portfolio of milestones and royalties through licensing activities. Additional information on the life science finance market is available on the Company’s website at www.swkhold.com.
https://www.prnewswire.com/news-releases/swk-holdings-confirms-receipt-of-non-binding-proposal-from-carlson-capital-lp-301431401.html
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
Recent SWKH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:31:36 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:14:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 10:26:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:09:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:09:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:08:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:08:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:30:39 PM
- SWK Holdings Corporation Announces Financial Results for Third Quarter 2023 • PR Newswire (US) • 11/09/2023 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:06:24 PM
- SWK Holdings Corporation to Report Third Quarter 2023 Financial Results • PR Newswire (US) • 11/06/2023 09:05:00 PM
- SWK Holdings Corporation Announces B. Riley Securities Exercises Option to Purchase Approximately $3 Million in Additional Unsecured Senior Notes • PR Newswire (US) • 10/30/2023 12:00:00 PM
- SWK Holdings Highlights Recent Achievements and Provides Portfolio Update • PR Newswire (US) • 10/18/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 12:00:40 PM
- SWK Holdings Corporation Increases Revolving Credit Facility to $60 Million • PR Newswire (US) • 10/11/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:34:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:33:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:33:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:33:10 PM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 10/03/2023 08:08:52 PM
- SWK Holdings Corporation Announces Closing of Public Offering of Senior Unsecured Notes Due 2027 • PR Newswire (US) • 10/03/2023 08:05:00 PM
- Form CERT - Certification by an exchange approving securities for listing • Edgar (US Regulatory) • 10/03/2023 07:12:07 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 09/29/2023 09:20:08 PM
- SWK Holdings Corporation Announces Pricing of Public Offering of Senior Unsecured Notes Due 2027 • PR Newswire (US) • 09/28/2023 10:34:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM